Abstract

A single point mutation in the lysosomal proenzyme receptor-inhibiting sequence near the N terminus of mouse procathepsin L can result in glycosylation of a normally cryptic site near its C terminus. When alanine replaced His36, Arg38, or Tyr40, the nascent chain of the mutant protein cotranslationally acquired a high mannose oligosaccharide chain at Asn268. In contrast, when alanine replaced Ser34, Arg37, or Leu39, this second carbohydrate chain was not added. This alternating pattern of abnormal glycosylation suggested that propeptide residues 36-40 normally assume an extended conformation having the side chains of residues 36, 38, and 40 facing in the same direction. When tyrosine conservatively replaced His36 or lysine replaced Arg38, Asn268 was not glycosylated. But the procathepsin L mutant having phenylalanine in place of Tyr40 was glycosylated at Asn268, which indicates that the hydrogen bond between the hydroxyl group of Tyr40 and the carboxylate group of Asp82 is necessary for normal folding of the nascent proenzyme chain. Mutation of the adjacent alpha2p (ERININ) helix of the propeptide or addition of a C-terminal epitope tag sequence to procathepsin L also induced misfolding of the proenzyme, as indicated by addition of the second oligosaccharide chain. In contrast, the propeptide mutation KAKK99-102AAAA had no effect on carbohydrate modification even though it reduced the positive charge of the proenzyme. Misfolded mutant mouse procathepsin L was not efficiently targeted to lysosomes on expression in human HeLa cells, even though it acquired phosphate on mannose residues. The majority of the mutant protein was secreted after undergoing modification with complex sugars. Similarly, epitope-tagged mouse procathepsin L was not targeted to lysosomes in homologous mouse cells but was efficiently secreted. Since production of mature endogenous protease was not reduced in cells expressing the tagged protein, the tagged protein did not compete with endogenous procathepsin L for targeting to lysosomes.

Highlights

  • Mutation of the adjacent ␣2p (ERININ) helix of the propeptide or addition of a C-terminal epitope tag sequence to procathepsin L induced misfolding of the proenzyme, as indicated by addition of the second oligosaccharide chain

  • We have found that mutation of any one of several LPR-inhibiting sequence (LIS) residues, which are located in the N-terminal 10% of the 317residue procathepsin L (procatL) chain, sufficiently changes the folding of the nascent chain during translation that it is glycosylated at Asn268, a normally cryptic site located in the C-terminal 20% of the procatL chain

  • The lysosomal proenzyme receptor (LPR)-Inhibiting Sequence (LIS) of ProcatL—Our previous studies indicated that the mannose 6-phosphate-independent association of mouse procatL with microsomal membranes at acidic pH requires the propeptide of the proenzyme [1]

Read more

Summary

EXPERIMENTAL PROCEDURES

Materials—Reagents used include the following: [35S]methionine (Trans35S-label; 850 –950 Ci/mmol) and [32P]orthophosphate (400 – 800 mCi/ml) from ICN Biomedicals, Costa Mesa, CA; Protein-A Sepharose CL4B from Pharmacia Biotech Inc.; Dulbecco’s modified Eagle’s medium, Opti-MEM, LipofectAMINE, and fetal bovine serum from Life Technologies, Inc.; aprotinin, dithiothreitol, endo-␤-N-acetylglucosaminidase H (EndoH), N-glycosidase F, HEPES, pepstatin, and phenylmethanesulfonyl fluoride from Boehringer Mannheim; enhanced chemiluminescence Western blotting detection reagents and donkey anti-rabbit and goat anti-mouse IgG conjugated to horseradish peroxidase from Amersham Corp.; Immobilon-P from Millipore, Bedford, MA; brefeldin A from Epicentre Technologies, Madison, WI; Muta-Gene in vitro mutagenesis kit and prestained molecular mass marker proteins from Bio-Rad; eukaryotic expression vector pSG5 from Stratagene, La Jolla, CA; prokaryotic expression vector pET-27b and HSV-Tag monoclonal antibody from Novagen, Madison, WI; plasmid purification columns from Qiagen, Chatsworth, CA; oligonucleotides from Lineberger lum; LIS, LPR-inhibiting sequence; PAGE, polyacrylamide gel electrophoresis; PBS, phosphate-buffered saline, pH 7.2; PCR, polymerase chain reaction; procatL, procathepsin L; HSV, herpes simplex virus; CAPS, 3-(cyclohexylamino)propanesulfonic acid. Nonspecific binding sites were blocked for 30 min with 0.5% non-fat dry milk (Carnation) in Tris buffer (10 mM, pH 7.5) containing NaCl

Removes phenolic ring at
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call